Application of influenza vaccine in preparation of medicament for treating allergic diseases and allergy related diseases

A technology for allergic diseases and influenza vaccines, which is applied in the field of application of influenza vaccines to the preparation of drugs for the treatment of allergic diseases and allergy-related diseases, can solve the problems of no recognized treatment methods, and achieve low cost, safe use, and effective treatment good effect

Inactive Publication Date: 2012-07-04
李炜长
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Allergic rhinitis (allergic rhinitis), secretory otitis media, eczema, and bronchial asthma are all clinically difficult to cure diseases. In the past, there were many

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Embodiment 1: the application of influenza vaccine in the medicine as the treatment allergic rhinitis, its method is:

[0022] Take the whole virus inactivated influenza vaccine and start vaccination at any time of the year. (Adults and children over three years old) Inoculation dose / dose: 15μg / 0.5ml, 1 dose; (Children six months to three years old) Inoculation dose / dose: 7.5μg / 0.25ml, 1 dose; Inoculation site: lateral deltoid muscle of the upper arm; Inoculation route: intramuscular injection, the second dose after 4 weeks, and the third dose at an interval of 4 weeks, 3 times Inoculate once every six months to consolidate the curative effect.

Embodiment 2

[0023] Embodiment 2: the application of influenza vaccine as the medicine for the treatment of bronchial asthma, its method is:

[0024] Inoculation with split influenza vaccine at any time of the year, (adults and children over three years old) vaccination dose / dose: 15μg / 0.5ml, 1 dose; (children six months to three years old) vaccination dose / Dosage: 7.5μg / 0.25ml, 1 dose; Inoculation site: deltoid muscle on the outer side of the upper arm; Inoculation route: Intramuscular injection, the second dose was inoculated 4 weeks later, and the third dose was inoculated 4 weeks later, every 8 Inoculate once a month to consolidate the curative effect.

Embodiment 3

[0025] Embodiment 3: the application of influenza vaccine in the medicine as the treatment of secretory otitis media, its method is:

[0026] The subunit influenza vaccine can be vaccinated at any time throughout the year, dose / dose: (adults and children over three years old) vaccination dose / dose: 15μg / 0.5ml, 1 dose; (six months to Three-year-old children) Inoculation dose / dose: 7.5μg / 0.25ml, 1 dose; Inoculation site: lateral deltoid muscle of upper arm; Inoculation route: intramuscular injection, the second dose after 4 weeks, and the third dose at an interval of 4 weeks , Inoculate once every 8 months after 3 times to consolidate the curative effect.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to application of an influenza vaccine in a medicament for treating allergic diseases and allergy related diseases. The specific method comprises that: the influenza vaccine is inoculated at any time all the year round; the first inoculation dose (for adults and children who are more than three years old) is 15mug/0.5ml every time; the 1st inoculation dose (for six-mouth-old children to children who are less than three years old) is 7.5mug/0.25ml every time; the inoculation part is the outside deltoid muscle of the upper arm; the inoculation path is intramuscular injection; and the 2nd dose is inoculated after 4 weeks, the 3rd dose is inoculated at another interval of 4 weeks, and the influenza vaccine is inoculated once every half to one year after 3 times of inoculation, so that the curative effect is solidified. The application field of the influenza vaccine is expanded, the influenza vaccine is applied to treatment of the allergic diseases and other allergy related diseases for the first time, and the influenza vaccine is safe in use and convenient, good in treatment effect and low in cost and is easily accepted by patients.

Description

technical field [0001] The invention relates to a new application of the influenza vaccine, in particular to the application of the influenza vaccine as a medicine for treating allergic diseases and diseases related to allergy. Background technique [0002] Allergic rhinitis, also known as allergic rhinitis, is an allergic disease of the nasal mucosa and can cause various complications. Sneezing, nasal itching, runny nose and nasal congestion are the four most common symptoms. Children can also see gray-blue annular shadows and folds under the eyes, which are called "allergic pigmentation" or "Dennie-Mergan infraorbital folds", which are caused by periorbital edema and venous stasis, and are also the cause of atopic children. A characteristic finding of oculo-nasal allergy in which internal examination of the nasal cavity reveals edematous turbinates, often pale or purple, covered by a thin layer of watery mucus. Swollen turbinates can completely block the nasal passages ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/145A61P37/08A61P11/02A61P11/06A61P27/16A61P17/00
Inventor 李炜长
Owner 李炜长
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap